The influence of platelet additive solutions on cytokine levels and complement activation in platelet concentrates during storage

Vox Sanguinis

Volumn 84, Issue 1, 2003, Pages 28-35

  Cardigan, Rebecca ^a   Sutherland, J ^b   Wadhwa, M ^b   Dilger, P ^b   Thorpe, R ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b NONE

Author keywords

Activation; Chemokine; Complement; Cytokine; Platelet; Storage

Indexed keywords

COMPLEMENT; CYTOKINE; MAGNESIUM; PADGEM PROTEIN; POTASSIUM; RANTES; THROMBOCYTE CONCENTRATE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; COMPLEMENT ACTIVATION; HUMAN; LEUKAPHERESIS; PLASMA; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE PRESERVATION; THROMBOCYTOPHERESIS;

BLOOD PLATELETS; BLOOD PRESERVATION; COMPLEMENT ACTIVATION; CYTOKINES; HUMANS; PHARMACEUTIC AIDS; PLATELET ACTIVATION; PLATELET TRANSFUSION;

EID: 0037991178     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2003.00257.x     Document Type: Article

References (45)

1. Muylle L, Joos M, Wouters E et al.: Increased tumor necrosis factor-α (TNF-α, interleukin-1 (IL-1), and interleukin-6 (IL-6) levels in the plasma of stored PCs: relationship between TNF-α and IL-6 levels and febrile transfusion reactions. Transfusion 1993; 33:195-199
2. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, Kelton JG: The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331:625-628
3. Bubel S, Wilhelm D, Entelmann M, Kirchner H, Klüter H: Chemokines in stored platelet concentrates. Transfusion 1996; 36:445-449
4. Wadhwa M, Seghatchian MJ, Lubenko A, Contreras M, Dilger P, Bird C, Thorpe R: Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays. Br J Haematol 1996; 93:225-234
5. Palmer DS, Aye MT, Dumont L, Dumont D, McCombie N, Giulivi A, Rutherford B, Trudel E, Hashemi-Tavoularis S: Prevention of cytokine accumulation in platelets obtained with the COBE spectra apheresis system. Vox Sang 1998; 75:115-123
6. Heddle NM, Klama L, Meyer R, Walker I, Boshkov L, Roberts R, Chambers S, Podlosky L, O'Hoski P, Levine M: A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion 1999; 39:231-238
7. Fujihara M, Ikehuchi K, Wakamoto S, Sekiguchi S: Effects of filtration and gamma radiation on the accumulation of RANTES and transforming growth factor-β1 in apheresis platelet concentrates during storage. Transfusion 1999; 39:498-505
8. Klüter H, Bubel S, Kirchner H, Wilhelm D: Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999; 39:1179-1184
9. Fava RA, Casey TT, Wilcox J, Pelton RW, Moses HL, Nanney LB: Synthesis of transforming growth factor-beta 1 by megakaryocytes and its localization to megakaryocyte and platelet alpha-granules. Blood 1990; 76:1946-1955
10. Klinger MH, Wilhelm D, Bubel S, Sticherling M, Schroder JM, Kuhn W: Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. Int Arch Allergy Immunol 1995; 107:541-546
11. Metcalfe P, Williamson LM, Reutelingsperger CPM, Swann I, Ouwehand WH, Goodall AH: Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Br J Haematol 1997; 98:86-95
12. Hagherg IA, Akkok CA, Lyherg T, Kjeldsen-Kragh J: Apheresisinduced platelet activation: comparison of three types of cell separators. Transfusion 2000; 40:182-192
13. de Wildt-Eggen J, Schrijver JG, Smid WM, Joie M, Bollinne V, Bins M: Platelets stored in a new-generation container: differences between plasma and platelet additive solution II. Vox Sang 1998; 75:218-223
14. Bunescu A, Hild M, Lundahl J, Egberg N: Platelet storage in PAS-2 or autologous plasma: impact on functional parameters. Transfus Med 2001;11:105-110
15. Gulliksson H: Additive solutions for the storage of platelets for transfusion. Transfus Med 2000; 10:257-264
16. Moroff G, Wagner S, Benade L, Dodd RY: Factors influencing virus inactivation and retention of platelet properties following treatment with aminomethyltrimethylpsoralen and ultraviolet light. Blood Cells 1992; 18:43-56
17. Gulliksson H, AuBuchon JP, Vesterinen M, Sandgren P, Larsson S, Pickard CA, Herschel I, Roger J, Tracy JE, Langweiler M: Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sang 2002; 82:131-136
18. Dumont LJ, Krailadsiri P, Seghatchian J, Taylor LA, Howell CA, Murphy MF: Preparation and storage characteristics of white cell-reduced high-concentration platelet concentrates collected by an apheresis system for transfusions in utero. Transfusion 2000; 40:91-100
19. Cardigan R, Phipps A, Seghatchian J, Bashir S, Aynsley S, Beckman N, Williamson LM: The development of a national standardised approach to the enumeration of residual leucocytes in blood components. Vox Sang 2002; 83:100-109
20. Wadhwa M, Seghatchian MJ, Dilger P, Sands D, Krailadsiri P, Contreras M, Thorpe R: Cytokines in WBC-reduced apheresis PCs during storage: a comparison of two WBC-reduction methods. Transfusion 2000; 40:1118-1126
21. George JN, Pickett EB, Heinz R: Platelet membrane glycoprotein changes during the preparation and storage of platelet concentrates. Transfusion 1988; 28:123-126
22. Fijnheer R, Modderman PW, Veldman H, Ouwehand WH, Nieuwenhuis HK, Roos D, De Korte D: Detection of platelet activation with monoclonal antibodies and flow cytometry. Transfusion 1990; 30:20-25
23. Rinder HM, Murphy M, Mitchell JG, Stocks J, Ault KA, Hillman RS: Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991; 31:409-414
24. Triulzi DJ, Kickler TS, Braine HG: Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion 1992; 32:529-533
25. Holme S, Sweeney JD, Sawyer S, Elfath MD: The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion 1997; 37:12-17
26. Reimers HJ, Packham MA, Kinlough-Rathbone RL, Mustard JF: Effect of repeated treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism and survival. Br J Haematol 1973; 25:675-689
27. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR: In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93:11877-11882
28. Berger G, Hartwell DW, Wagner DD: P-selectin platelet clearance. Blood 1998; 92:4446-4452
29. Koerner K, Weihe R, Sahlmen P, Zeller B, Seifried E, Cardoso M, Kubanek B: Quality of pooled platelet concentrates prepared from buffy coats and stored in an additive solution after filtration. Ann Hematol 1995; 70:97-102
30. de Wildt-Eggen J, Nauta S, Schrijver JG, van Marwijk Kooy M, Bins M, van Prooijen HC: Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study. Transfusion 2000; 40:398-403
31. Darbonne WC, Rice GC, Mohler MA et al.: Red blood cells are a sink for interleukin-8, a leukocyte chemotaxin. J Clin Invest 1991; 88:1362-1369
32. Horuk R, Chitnis C, Darbonne W et al.: A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993; 261:1182-1184
33. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ: Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993; 268:12247-12249
34. Dawson TC, Lentsch AB, Wang Z et al.: Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 2000; 96:1681-1684
35. Wahl SM: Transforming growth factor beta in inflammation. A cause and a cure. J Clin Immunol 1992; 12:61-74
36. McCartney-Francis N, Mizel D, Wong H, Wahl LM, Wahl SM: TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factors 1990; 4:27-35
37. McCartney-Francis NL, Wahl SM: Transforming growth factor β: a matter of life and death. J Leukoc Biol 1994; 55:401-409
38. Tsunawaki S, Sporn M, Ding A, Nathan C: Deactivation of macrophages by transforming growth factor-β. Nature 1988; 334:260-263
39. Jacobsen FW, Stokke T, Jacobsen SE: Transforming growth factor-beta potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood 1995; 86:2957-2966
40. Kunz D, Luley C, Heim MU, Bock M: Transforming growth factor beta is increased in plasma of patients with hematologic malignancies after transfusion of platelet concentrates. Transfusion 1998; 38:156-159
41. Bode AP, Miller DT, Newman SL, Castellani WJ, Norris HT: Plasmin activity and complement activation during storage of citrated platelet concentrates. J Lab Clin Med 1989; 113:94-102
42. Miletic VD, Popovic O: Complement activation in stored platelet concentrates. Transfusion 1993; 33:150-154
43. Holme S, Snyder E, Heaton A, Keegan T, Napychank P: In vitro and in vivo evaluation of cotton wool filtration of platelet concentrates obtained by automated and manual apheresis. Transfusion 1992; 32:328-333
44. Cardigan R, Sutherland J, Garwood M, Krailadsiri P, Seghatchian J, Beard M, Beckman N, Williamson LM: The effect of leucocyte depletion on the quality of fresh-frozen plasma (FFP). Br J Haematol 2001; 114:233-240
45. Polley MJ, Nachman RL: Human platelet activation by C3a and C3a des-arg. J Exp Med 1983; 158:603-615